Relevant bibliographies by topics / National Council on Drug Abuse Control

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Reports

Academic literature on the topic 'National Council on Drug Abuse Control'

Author: Grafiati
Published: 4 June 2021
Last updated: 8 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'National Council on Drug Abuse Control.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "National Council on Drug Abuse Control"

1

Siff, Stephen. "“Why Do You Think They Call It Dope?”: Richard Nixon’s National Mass Media Campaign Against Drug Abuse." Journalism & Communication Monographs 20, no. 3 (August 15, 2018): 172–247. http://dx.doi.org/10.1177/1522637918787804.

Full text
Abstract:
This monograph explores how corporate, political, and public health concerns shaped the Nixon administration’s public service advertising campaign against drug abuse. Between 1970 and 1973, the Nixon administration worked with the nonprofit Advertising Council to orchestrate a national, “one-voice” mass media campaign to change Americans’ attitudes toward the use of drugs. Papers preserved in the archives of the Advertising Council and by Nixon administration officials expose behind-the-scenes conflicts over the government’s drug-abuse message among the White House, federal agency staff, and private partners in the campaign, including drug companies and the advertising and broadcasting industries. Controversies included whether to include alcohol, marijuana, legally marketed prescription drugs such as amphetamines, and dangerous retail drugs such as headache medicines and caffeine, and whether the campaign should promote safe drug use or only discourage “abuse.” Archival records reveal the president’s power to set the government’s message, despite bureaucratic and expert resistance. However, government control over the propaganda campaign was limited by reliance on the Ad Council and the voluntary participation of networks and broadcasters to distribute public service announcements (PSAs). Through the Ad Council’s process of reviewing and obtaining broadcast network clearances for individual PSAs, advertisements that disparaged alcohol and other legally advertised products were weeded from the national campaign. Ultimately, the White House’s vision of a mass media offensive against drug abuse in all its forms was implemented primarily as a campaign against the use of illegal drugs, particularly by youth. Although successful with broadcasters, the campaign was terminated in 1973 amid concerns it was actually stimulating illegal drug use.
APA, Harvard, Vancouver, ISO, and other styles
2

Gibtiah, Gibtiah. "PERLINDUNGAN HUKUM TERHADAP KONSUMEN ATAS PENGGUNAAN BAHAN FORMALIN PADA MAKANAN DALAM PERSPEKTIF HUKUM ISLAM." Nurani: Jurnal Kajian Syari'ah dan Masyarakat 19, no. 1 (June 28, 2019): 49–62. http://dx.doi.org/10.19109/nurani.v19i1.2721.

Full text
Abstract:
In food production, many producers use food technology that makes food quickly damaged, becomes durable and stays good, by adding preservatives. so that the food can remain fresh, smell and taste unchanged, not quickly damaged or rot due to exposure to bacteria / fungi, however, many manufacturers cheat by adding preservatives that are harmful to the body, and can rob human lives, such as formalin, substances Formalin is a chemical that is used for external purposes, which if consumed will cause many negative effects on the body. The use of formaldehyde is prohibited in the use of additives in food. and can be held accountable for penalties in the form of administrative sanctions and penalties. So how is the legal protection of consumers using formalin hazardous substances according to the Consumer Protection Act? And what is the view of Islamic law on the practice of using formaldehyde in food? and what is the role of relevant institutions to protect consumers from formalin-related additives in Palembang City? Legal protection for consumers of formalin substances in the form of regulations and laws, among others: business actors are held accountable for losses suffered by consumers (Article 15 of the Consumer Protection Act Number 8 of 1999. Whereas in Islamic law regarding food containing formalin ingredients) , categorized as illegitimate to be eaten because it has been mixed between the halal and the haram.Based on the Fatwa of the Indonesian Ulema Council Number: 43 of 2012 concerning Formalin Abuse and other Hazardous Substances, formalin food is prohibited because it brings harm, ie if swallowed it can irritate the stomach, nausea, vomiting, and can lead to death, while those that are related to consumer protection are: a). Drug and Food Control Agency (BPOM); b). Institute for Self-Help Consumer Protection (LPKSM); c). National Consumer Protection Agency (BPKN) and d).Indonesian Consumers Foundation (YLKI). Keywords: Formalin, Undang-Undang Perlindungan Konsumen, halal food.
APA, Harvard, Vancouver, ISO, and other styles
3

Manchikanti, Laxmaiah. "National Drug Control Policy and Prescription Drug Abuse: Facts and Fallacies." Pain Physician 3;10, no. 5;3 (May 14, 2007): 399–424. http://dx.doi.org/10.36076/ppj.2007/10/399.

Full text
Abstract:
In a recent press release Joseph A. Califano, Jr., Chairman and President of the National Center on Addiction and Substance Abuse at Columbia University called for a major shift in American attitudes about substance abuse and addiction and a top to bottom overhaul in the nation’s healthcare, criminal justice, social service, and eduction systems to curtail the rise in illegal drug use and other substance abuse. Califano, in 2005, also noted that while America has been congratulating itself on curbing increases in alcohol and illicit drug use and in the decline in teen smoking, abuse and addition of controlled prescription drugs-opioids, central nervous system depressants and stimulants-have been stealthily, but sharply rising. All the statistics continue to show that prescription drug abuse is escalating with increasing emergency department visits and unintentional deaths due to prescription controlled substances. While the problem of drug prescriptions for controlled substances continues to soar, so are the arguments of undertreatment of pain. The present state of affairs show that there were 6.4 million or 2.6% Americans using prescription-type psychotherapeutic drugs nonmedically in the past month. Of these, 4.7 million used pain relievers. Current nonmedical use of prescription-type drugs among young adults aged 18-25 increased from 5.4% in 2002 to 6.3% in 2005. The past year, nonmedical use of psychotherapeutic drugs has increased to 6.2% in the population of 12 years or older with 15.172 million persons, second only to marijuana use and three times the use of cocaine. Parallel to opioid supply and nonmedical prescription drug use, the epidemic of medical drug use is also escalating with Americans using 80% of world’s supply of all opioids and 99% of hydrocodone. Opioids are used extensively despite a lack of evidence of their effectiveness in improving pain or functional status with potential side effects of hyperalgesia, negative hormonal and immune effects, addiction and abuse. The multiple reasons for continued escalation of prescription drug abuse and overuse are lack of education among all segments including physicians, pharmacists, and the public; ineffective and incoherent prescription monitoring programs with lack of funding for a national prescription monitoring program NASPER; and a reactive approach on behalf of numerous agencies. This review focuses on the problem of prescription drug abuse with a discussion of facts and fallacies, along with proposed solutions. Key words: Prescription drug abuse, opioid abuse, opioid misuse, National Drug Control Policy, NASPER, prescription drug monitoring programs.
APA, Harvard, Vancouver, ISO, and other styles
4

Westermeyer, Joseph. "National and International Strategies to Control Drug Abuse." Advances in Alcohol & Substance Abuse 8, no. 2 (December 1989): 1–35. http://dx.doi.org/10.1300/j251v08n02_01.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Abd-Elsayed, Alaa. "Prescription Drugs and the US Workforce: Results from a National Safety Council Survey." Pain Physician 1;23, no. 1;1 (January 14, 2020): 1–16. http://dx.doi.org/10.36076/ppj.2020/23/1.

Full text
Abstract:
Background: The cost of chronic pain in the United States is extremely high. Opioids are one of the most common medications prescribed for the treatment of chronic pain, and their misuse and addiction have been of concern. It has been found that opioids are frequently abused and negatively impact the American workforce. Objectives: The objective of this study was to obtain data on US employers’ concerns and priorities, perceptions of prescription drug abuse, perceived impact of prescription drug use on the workplace, identification of and response to drug abuse, perceived ability to handle prescription drug abuse in the workplace, and workplace initiatives, employee assistance programs, employee drug testing, workplace prescription drug training, insurance coverage of alternative treatment, and overall preparedness to deal with the issue. Study Design: This research used an employer proprietary questionnaire created by members of the National Safety Council in cooperation with market research experts at B2B International. Setting: Employers surveyed via an online survey represent diverse industries and geographical areas. Methods: The research was conducted using a proprietary questionnaire. Participants were recruited from a sample of verified panelists through Research Now, and fieldwork was conducted online by B2B International. This report is on 501 interviews that each represent a US employer with 50 or more employees. The employers sampled are extremely diverse in not only size and industry, but also geography and centralization. Results: Our results showed that 67% of employers reported concerns related to prescription drug misuse, which was comparable to workplace violence and more concerning than the use of illegal drugs. Sixty-one percent reported concerns related to prescription opioids, which was a higher concern than using anti-anxiety medications, stimulants, and even heroin. Limitations: Survey study with descriptive analysis with limited sample. Conclusions: Prescription drug misuse and abuse concern American employers. Their side effects are clear, but employers are less likely to acknowledge their detrimental business effect. Employers report being unprepared for dealing with issues related to this; however, the firms with programs in place feel more prepared to deal with misuse and abuse. Key words: Prescription drugs, US workforce, chronic pain
APA, Harvard, Vancouver, ISO, and other styles
6

Kurke, Martin I. "Congressional review of national problems in drug abuse and its control." Behavioral Sciences & the Law 3, no. 3 (June 1985): 241–48. http://dx.doi.org/10.1002/bsl.2370030302.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kurke, Martin I. "Congressional review of national problems in drug abuse and its control." Journal of the History of the Behavioral Sciences 3, no. 3 (1985): 241–48. http://dx.doi.org/10.1002/1520-6696(1985)3:3<241::aid-jhbs2300030303>3.0.co;2-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gillespie, Nathan A., Anjali K. Henders, Tracy A. Davenport, Daniel F. Hermens, Margie J. Wright, Nicholas G. Martin, and Ian B. Hickie. "The Brisbane Longitudinal Twin Study: Pathways to Cannabis Use, Abuse, and Dependence Project—Current Status, Preliminary Results, and Future Directions." Twin Research and Human Genetics 16, no. 1 (November 28, 2012): 21–33. http://dx.doi.org/10.1017/thg.2012.111.

Full text
Abstract:
We describe the data being collected from the Brisbane Longitudinal Twin Study in Australia as part of the US National Institute on Drug Abuse (NIDA)-funded project, Pathways to Cannabis Use, Abuse and Dependence. The history, recruitment, assessment, and retention of twin families in this project are described in detail, along with preliminary findings and plans for future research. The goal of this NIDA project is to make a significant contribution to the discovery of quantitative trait loci influencing cannabis use disorders. Although the focus is cannabis use, abuse, and dependence in young adults, measures of comorbid illicit drug use disorders are also being collected. In addition, a variety of internalizing and externalizing disorders are being assessed, funded by support from the Australian National Health and Medical Research Council. Because these same twins have participated in numerous twin studies since 1992, future plans will include linking different phenotypes to investigate relationships between drug use, psychiatric disorders, and psychological phenotypes within cross-sectional and longitudinal or developmental frameworks.
APA, Harvard, Vancouver, ISO, and other styles
9

Standefer, J. C., and R. C. Backer. "Drug screening with EMIT reagents: a quantitative approach to quality control." Clinical Chemistry 37, no. 5 (May 1, 1991): 733–38. http://dx.doi.org/10.1093/clinchem/37.5.733.

Full text
Abstract:
Abstract We investigated the precision, linearity, accuracy, and stability of quantitative results for five drugs of abuse [amphetamines, benzoylecgonine, opiates, phencyclidine, and the cannabinoid-tetrahydrocannabinol (THC)-9-acid metabolite], analyzed in control specimens by using EMIT d.a.u. reagents (Syva Co.) with a Monarch 2000 analyzer with a nonlinear interpolation curve-fitting algorithm. The within-day and between-days coefficients of variation (CVs) were less than 5% for all drugs except THC-9-acid, which had a CV between 10% and 20%. The drift of control values during a 30-day stability study was less than 10% from target values for three weeks after a single calibration, except for THC-9-acid control values, which were stable for only two to three days. Daily calibration reduced the drift away from target values during the 30-day stability study and produced optimum precision of all drug assays. Mean control values near the National Institute on Drug Abuse cutoff limits were within 10% of their target values.
APA, Harvard, Vancouver, ISO, and other styles
10

Ramlagan, Shandir, Karl Peltzer, and Gladys Matseke. "Epidemiology of drug abuse treatment in South Africa." South African Journal of Psychiatry 16, no. 2 (April 1, 2010): 10. http://dx.doi.org/10.4102/sajpsychiatry.v16i2.172.

Full text
Abstract:
<p><strong>Background.</strong> The aim of the study was to explore the epidemiology of drug abuse treatment in South Africa.</p><p><strong>Methods.</strong> Treatment demand statistics were analysed from South African National Council on Alcoholism and Drug Dependence and the South African Community Epidemiology Network on Drug Use records, and a rapid situation assessment was conducted. Twenty-one key informant interviews were conducted in all 9 provinces among provincial substance abuse co-ordinators, and one manager per treatment centre from a sample of treatment centres. Three focus groups were conducted and 46 self-administered questionnaires were distributed among inpatients at 2 selected treatment centres in Free State and North West provinces. Qualitative data were analysed using grounded theory, and quantitative data analysed using SPSS. <strong></strong></p><p><strong>Results.</strong> Treatment records show that the most frequent substance of abuse was alcohol (51%), followed by cannabis (21%), crack/cocaine (9.6%), heroin/opiates (7.9%), methamphetamine (Tik) (4.5%), prescription/over-the-counter drugs (2.0%), and cannabis/mandrax (1.7%). More substance abusers were male, of lower education, white or black, than were female, more highly educated, coloured and Indian/Asian. Key informant interviews showed that females are the ‘hidden’ substance abusers and tend not to be identified in research statistics and at treatment centres. Poverty, unemployment, lack of recreational facilities, being surrounded by substance abusers, and long work shifts were also mentioned as factors contributing to substance abuse. The age of initiation of substance abuse using non-drugs such as glue was 9 years old, alcohol 10 - 12 years old, dagga 11 - 12 years old, poly-drug use (alcohol, tobacco and dagga) 14 years old, and harder drugs such as cocaine and heroin at 16 - 17 years old, as reported by key informants. Family care and support, improved socio-economic conditions and increased law enforcement would help to discourage substance abuse.</p><p><strong>Conclusion.</strong> Prevention interventions and policies in South Africa should focus on reducing substance abuse by targeting the ‘at risk populations’ identified in this study.</p>
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "National Council on Drug Abuse Control"

1

Selipsky, Lisa. "The design of a service outcome measure for SANCA." Thesis, 2012. http://hdl.handle.net/10210/4437.

Full text
Abstract:
M.A.
The treatment of substance abuse remains a challenging process with relapse an ever-present risk. For those offering treatment within this field, such as the South African National Council on Alcoholism and Drug Dependence (SANCA), it is of cardinal importance to evaluate the outcomes of their interventions. Currently, there is no quantifiable and standardised method that SANCA can use to establish and assess how the actual outcomes of their programmes compare to their intended programme goals. Kranz and O’Hare (2006) argue for the evaluation of substance abuse treatment programmes through the use of scales to quantify various aspects of the treatment process which can then serve as a measure of its effectiveness. Effectiveness in this instance refers broadly to a patient’s maintenance of his/her sobriety for a period of 12 months or more, combined with an increase in his/her general functioning. Therefore, this study aims to demonstrate the technically complex process of developing a content valid framework for a scale on behalf of SANCA that adheres to their requirements for programme evaluation. The study is guided by an adapted model of ecometric scale development presented schematically by Faul and Hudson (1999). Through the use of a grounded theory approach, the study shows how to identify the expectations for a scale in the organisation and organise SANCA’s treatment strategy into a framework within which the areas of measurement can be placed. The study then demonstrates the construction of operational assessment areas through empirical data collection that adequately reflects such expectations. It also serves to test for content validity of the assessment areas, through the application of domain sampling theory. The study reveals the process undertaken to convert those assessment areas into constructs by conceptualising and operationalising them into working definitions. Lastly, drawing on those defined constructs, it populates a series of exemplar items designed for illustrative purposes.
APA, Harvard, Vancouver, ISO, and other styles
2

Opperman, Hester Catharina. "Behandelingsbehoeftes van Heroïenafhanklikes met spesiale verwysing na SANRA Kliniek, Witbank." Thesis, 2006. http://hdl.handle.net/10500/721.

Full text
Abstract:
The motivation for this study is the increase of treatment needs of heroin dependents at SANCA, (South African National Council of Alcohol and Drug Abuse) Witbank. SANCA Witbank wants to ensure that the most effective treatment can be supplied. Research goals are to:  Do a literature study of out-patient treatment programmes.  Assess the needs of heroin out-patient dependents with regard to out-patient treatment programmes.  Make recommendations with regard to out-patient treatment programmes for heroin dependents. It was an exploratory research subject and the data collection methods were qualitative and quantitative. Interview schedules were used as research tools. Schedule B was completed by the researcher with heroin dependents that visited SANCA Witbank for the period 31 January 2005 to 4 February 2005. Schedule A was completed by the researcher with personnel of SANCA out-patient clinics and the questions were discussed and completed telephonically. The conclusion is that the treatment programme of SANCA Witbank is in line with the rest of the drug dependent field and only minimal recommendations were made.
Social Work
MA(SS)(MENTAL HEALTH)
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "National Council on Drug Abuse Control"

1

United States. Office of National Drug Control Policy. National drug control strategy. Washington, D.C: White House, Office of National Drug Control Policy, Executive Office of the President, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Williams, Heather G. National drug control strategy. New York: Nova Science Publishers, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

United States. Office of National Drug Control Policy. National drug control strategy. Washington, D.C: For sale by the Supt. of Docs., U.S. G.P.O., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

United States. Office of National Drug Control Policy. National drug control strategy. Washington, D.C: White House, Office of National Drug Control Policy, Executive Office of the President, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Turner, Benjamin F. U.S. national drug control strategy. Hauppauge, N.Y: Nova Science Publishers, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

United States. Office of National Drug Control Policy. The National Drug Control Strategy: 1997. Washington: White House, Office of National Drug Control Policy, Executive Office of the President, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zambia. National drug control strategy master plan. [Lusaka]: The Government, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

United States. Congress. Senate. Committee on the Judiciary. Review of the national drug control strategy. Washington: U.S. G.P.O., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

United States. Office of National Drug Control Policy. National Drug Control Strategy: 1999. Washington, D.C: White House, Office of National Drug Control Policy, Executive Office of the President, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Policy, United States Office of National Drug Control. The 1999 National Drug Control Strategy overview briefing. [Washington, D.C: Executive Office of the President, Office of National Drug Control Policy, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "National Council on Drug Abuse Control"

1

Hoffmeister, Friedrich, and Günther Stille. "Drug Abuse: Control Through National and International Regulatory Practice." In Pain, 44–49. Vienna: Springer Vienna, 1987. http://dx.doi.org/10.1007/978-3-7091-6975-9_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kleiman, Mark A. R., Jonathan P. Caulkins, and Angela Hawken. "What Are the Benefits of Drug Use?" In Drugs and Drug Policy. Oxford University Press, 2011. http://dx.doi.org/10.1093/wentk/9780199764518.003.0008.

Full text
Abstract:
Can abusable drugs be beneficial? Yes, in many ways, some recognized by the current laws, others not. The international drug-control treaties and associated national drug-control laws include explicit lists (“schedules”) of substances that have medical use and also carry a risk of abuse. Painkillers, notably...
APA, Harvard, Vancouver, ISO, and other styles
3

Hoge, Michael A., Gail W. Stuart, John A. Morris, Leighton Y. Huey, Michal T. Flaherty, and Manuel Paris Jr. "Behavioral Health Workforce Development in the United States." In Substance Abuse and Addiction, 433–55. IGI Global, 2019. http://dx.doi.org/10.4018/978-1-5225-7666-2.ch023.

Full text
Abstract:
Mental health and substance use conditions are among the most prominent causes of illness and disability in the U.S. Yet less than half of the individuals with these conditions receive treatment (Substance Abuse and Mental Health Services Administration [SAMHSA], 2011; Office of National Drug Control Policy [ONDCP], 2013). While there are many impediments to accessing care, the absence of a workforce that is of sufficient size and adequately trained is a significant factor (Olfson, 2016). This chapter provides an overview of the U.S. behavioral health workforce and describes seven strategic areas in which activity has been undertaken to strengthen it. The initiatives of the Annapolis Coalition on the Behavioral Health Workforce are presented to highlight these strategic areas, which include assessment and planning; competency identification and development; roles for persons in recovery and family members; integrated care and interprofessional collaboration; workforce development in substance use; diversity and cultural competency; and knowledge dissemination and adoption of best practices.
APA, Harvard, Vancouver, ISO, and other styles
4

Crandall, Russell. "Reagan’s War." In Drugs and Thugs, 153–72. Yale University Press, 2020. http://dx.doi.org/10.12987/yale/9780300240344.003.0012.

Full text
Abstract:
This chapter discusses how the U.S. nation witnessed a second heroin epidemic in the second half of the 1970s that terrified politicians and tore open the social fabric of inner cities across America. It mentions the National Household Survey on Drug Abuse that began using a new metric in the early 1970s that included a question about drug use in the “last month.” It also recounts how cocaine that was supplied by enterprising and ruthless Colombian traffickers came to grip America like no other drug before it, referencing magazines like Newsweek that characterized cocaine as the status symbol of the American middle-class pothead. The chapter talks about how Ronald Reagan, who took the further step of establishing a new agency, the Drug Abuse Policy Office, which became the White House's Office of National Drug Control Policy. It explains Operation Pipeline, which escalated “pretextual traffic stops” and “consent searches” to leverage consent to search for drugs.
APA, Harvard, Vancouver, ISO, and other styles
5

Winter, Jerrold. "Pharmacological Puritanism and the War on Drugs: All the King’s Horses and All the King’s Men . . ." In Our Love Affair with Drugs. Oxford University Press, 2020. http://dx.doi.org/10.1093/oso/9780190051464.003.0013.

Full text
Abstract:
H. L. Mencken, arguably the leading satirist of the 20th century, said that American puritanism is characterized by the haunting fear that someone, somewhere, may be happy. If the source of that happiness is a drug, we might call it pharmacological puritanism. Followers of that faith abound, but I will mention just few. “There’s no such thing as recreational drug use” were the words of William Weld, head of the criminal division of the Attorney General’s office in 1988. A year later, in the midst of a cocaine epidemic, William Bennett, the first director of the Office of National Drug Control Policy (ONDCP) under President George H. W. Bush, expressed dual goals. The first was to construct 95,000 more federal prison cells for drug abusers and the second to make Washington, D.C., a drug-free city. He believed that calls for legalization of any psychoactive drug to be “morally scandalous.” John Walters, director of the ONDCP during George W. Bush’s tenure as president, believed that religion is the answer to drug abuse. Lest we think that pharmacological puritanism is a dying faith, we need only recall Attorney General Jeff Sessions’ comment in 2016 that “Good people don’t smoke marijuana.” It does make me wonder where, on the good–bad spectrum, lie the tens of millions of Americans who live in states and in the District of Columbia where marijuana is legal for recreational use. Among the general population, pharmacological puritanism appears to be uncommon. A survey of American college students found that the prime motives for drug use were to help with concentration, to increase alertness, and to get high. From the United Kingdom, David Nutt, chairman of the Department of Neuropsychopharmacology at Imperial College London, put it this way: “Drugs are taken for pleasure.” Whatever their numbers today or in the past, it is believers in pharmacological puritanism, with the absolutism which accompanies that faith, who are major contributors to the failure of our most recent war on drugs, now nearly a half-century old.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "National Council on Drug Abuse Control"

1

Norsworthy, Sarah, Rebecca Shute, Crystal M. Daye, and Paige Presler-Jur. National Institute of Justice’s Forensic Technology Center of Excellence 2019 National Opioid and Emerging Drug Threats Policy and Practice Forum. Edited by Jeri D. Ropero-Miller and Hope Smiley-McDonald. RTI Press, July 2020. http://dx.doi.org/10.3768/rtipress.2020.cp.0011.2007.

Full text
Abstract:
The National Institute of Justice (NIJ) and its Forensic Technology Center of Excellence (FTCoE) hosted the National Opioid and Emerging Drug Threats Policy and Practice Forum on July 18–19, 2019, in Washington, DC. The forum explored ways in which government agencies and programs, law enforcement officials, forensic laboratory personnel, medical examiners and coroners, researchers, and other experts can cooperate to respond to problems associated with drug abuse and misuse. Panelists from these stakeholder groups discussed ways to address concerns such as rapidly expanding crime laboratory caseloads; workforce shortages and resiliency programs; analytical challenges associated with fentanyl analogs and drug mixtures; laboratory quality control; surveillance systems to inform response; and policy related to stakeholder, research, and resource constraints. The NIJ Policy and Practice Forum built off the momentum of previous stakeholder meetings convened by NIJ and other agencies to discuss the consequences of this national epidemic, including the impact it has had on public safety, public health, and the criminal justice response. The forum discussed topics at a policy level and addressed best practices used across the forensic community.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'National Council on Drug Abuse Control' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography